DIP Corporation (2379) Q3 2025 earnings summary

Executive summary

• Q3 FY2025 saw 3.8% year-over-year sales growth, with operating profit down 6.2% due to higher advertising investments and a focus on innovation, including new services like Spot Baitoru, dip AI, and Baitoru Talk.

• Organizational shift from regional to industry-based sales teams aims to boost productivity and expertise, with high employee motivation from new initiatives and marketing campaigns.

• Company-wide dip AI Force project and large-scale promotions for dip AI are driving productivity improvements.

• Investments in sales capabilities included new graduate hires and office expansions.

Financial highlights

• Q3 FY'25/2 sales were ¥14,227 million (+3.8% YoY), operating income ¥3,365 million (-6.2% YoY), and net income ¥2,314 million (-6.0% YoY); nine-month sales reached ¥42,652 million (+6.0% YoY), operating income ¥10,881 million (+10.8% YoY), and net income ¥7,361 million (+7.8% YoY).

• DX business sales rose 12% year-over-year in Q3 and 14.8% for the nine months, with segment profit up 25% in Q3 and 19.9% for the nine months.

• Personnel Recruiting Segment sales were ¥12,529 million (+2.8% YoY) in Q3 and ¥37,615 million (+4.9% YoY) for the nine months, with segment profit of ¥4,459 million (-1.4% YoY) in Q3 and ¥14,838 million (+17.4% YoY) for the nine months.

• Permanent placement service sales fell 2.3% year-over-year in Q3, impacted by fewer new graduate hires.

• Basic earnings per share increased to ¥137.80 from ¥123.22 year-over-year.

Outlook and guidance

• Full-year FY’25/2 forecast unchanged: sales ¥57,600 million (+7.1% YoY), operating income ¥13,400 million (+5.0%), net income ¥8,900 million (-1.7%), and dividend at ¥95 per share.

• Expecting improved sales growth in Q4, especially in media and permanent placement services, with continued focus on expanding sales in logistics, office, and medical care fields.

• Market for part-time job ads expected to remain flat; continued cautious outlook due to weak market sentiment.